Surgepays, Inc. insider trading
Every open-market purchase and sale by Surgepays, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Surgepays, Inc.’s insiders pay?
From October 28, 2020 to June 5, 2026, 4 insiders reported 17 open-market purchases and 7 sales not made under a pre-set plan in Surgepays, Inc. Twelve months after each purchase was reported, the shares were −93.5% against the S&P 500 on average (median −93.5%), over 1 purchase with a full year of prices; 0% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on August 17, 2023 into $6,061 by November 2, 2026, −14.5% a year. It held shares 27% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $14,214 (+11.6% a year), and held throughout $18,042 (+20.3%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Cox Kevin Brian | CEO and Chairman of Board | 13 | −93.5% (1) | 0% | 0 | — | May 19, 2025 |
| Evers Anthony George | Chief Financial Officer | 0 | — | — | 6 | — | December 4, 2024 |
| May David Allen | DIRECTOR | 3 | — | — | 1 | — | June 5, 2026 |
| Weisberg Laurie | Director | 1 | — | — | 0 | — | November 25, 2024 |